PlumX Metrics
Embed PlumX Metrics

Glioblastoma management in a lower middle-income country: Nationwide study of compliance with standard care protocols and survival outcomes in Ukraine

Neuro-Oncology Practice, ISSN: 2054-2585, Vol: 10, Issue: 4, Page: 352-359
2023
  • 4
    Citations
  • 0
    Usage
  • 3
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Romodanov Neurosurgery Institute Researcher Publishes New Studies and Findings in the Area of Glioblastomas (Glioblastoma management in a lower middle-income country: nationwide study of compliance with standard care protocols and survival ...)

2022 DEC 15 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Daily -- New research on glioblastomas is the subject of a

Article Description

Background: The effective treatment of high-grade gliomas is a complex problem that requires ubiquitous implementation of sophisticated therapy protocols. The present study aimed to perform population-based analysis of glioblastoma management in lower-middle-income countries. Methods: The National Cancer Registry of Ukraine was screened for the records of adult patients with primary glioblastomas diagnosed in 2015-2019. Survival analysis was performed using Kaplan-Meier method and a multivariable Cox model. Results: A total of 2973 adult patients with histologically confirmed glioblastoma were included in the study. Mean age of patients was 55.6 ± 11.4 years, males slightly prevailed - 1541 (51.8%) cases. The completed clinical protocol including surgery followed by chemoradiotherapy was applied only in 658 (19.0%) patients. The minority of patients 743 (25.0%) were treated at the academic medical centers, where patients were more likely to receive combined treatment 70.1% compared with 57.9% (P = .0001) at the community hospitals. The overall median survival was 10.6 ± 0.2 months, and the 2-year survival rate was 17%. The number of utilized treatment modalities contributed to better survival rates and was associated with lower hazard ratio: Protocol with 2 modalities - 0.62 (P = .0001), 3 modalities - 0.48 (P = .0001). Conclusions: The management of glioblastoma in lower-middle-income countries is characterized by insufficient availability of treatment in academic medical centers and low rates of advanced therapy application. Survival analysis showed similar prognostic risk factors and outcomes compared with high-income countries.

Bibliographic Details

Rozumenko, Artem; Kliuchka, Valentyn; Rozumenko, Volodymir; Daschakovskiy, Andriy; Fedorenko, Zoja

Oxford University Press (OUP)

Medicine; Neuroscience

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know